Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

5.52
Delayed Data
As of 3:59pm ET
 -0.35 / -5.96%
Today’s Change
3.50
Today|||52-Week Range
17.87
-23.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization178.0K174.0K175.0K162.0K
 
 
 
 
 
 
Operating ExpensesGross Income-178.0K-174.0K-175.0K-162.0K
 
 
 
 
 
General Expenses5.3M5.6M5.7M5.1M
 
 
 
 
 
Research And Development2.3M2.5M2.4M2.8M
 
 
 
 
 
Total Operating Expenses5.5M5.8M5.9M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.5M-5.8M-5.9M-5.3M
 
 
 
 
 
Extraordinary Credit0.000.003.6M545.0K
 
 
 
Extraordinary Charge-10.3M-4.7M0.000.00
 
 
 
Interest Expense On Debt34.0K32.0K32.0K75.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-10.4M-2.3M-4.7M
 
 
 
 
 
Net Income-15.8M-10.4M-2.3M-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M26.5M27.0M27.6M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M26.5M27.0M27.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.56-$0.39-$0.09-$0.17
 
 
 
 
 
EPS Diluted-$0.64-$0.39-$0.09-$0.17